Morita TY - Search Results

1

CDC7 inhibition induces replication stress-mediated aneuploid cells with an inflammatory phenotype sensitizing tumors to immune checkpoint blockade.

Morita TY, Yu J, Kashima Y, Kamata R, Yamamoto G, Minamide T, Mashima C, Yoshiya M, Sakae Y, Yamauchi T, Hakozaki Y, Kageyama SI, Nakamura A, Lightcap E, Tanaka K, Niu H, Kannan K, Ohashi A. Morita TY, et al. Nat Commun. 2023 Nov 18;14(1):7490. doi: 10.1038/s41467-023-43274-3. Nat Commun. 2023. PMID: 37980406 Free PMC article.

2

Combination treatment with a PI3K/Akt/mTOR pathway inhibitor overcomes resistance to anti-HER2 therapy in PIK3CA-mutant HER2-positive breast cancer cells.

Fujimoto Y, Morita TY, Ohashi A, Haeno H, Hakozaki Y, Fujii M, Kashima Y, Kobayashi SS, Mukohara T. Fujimoto Y, et al. Among authors: morita ty. Sci Rep. 2020 Dec 10;10(1):21762. doi: 10.1038/s41598-020-78646-y. Sci Rep. 2020. PMID: 33303839 Free PMC article.

3

Distant N- and C-terminal domains are required for intrinsic kinase activity of SMG-1, a critical component of nonsense-mediated mRNA decay.

Morita T, Yamashita A, Kashima I, Ogata K, Ishiura S, Ohno S. Morita T, et al. J Biol Chem. 2007 Mar 16;282(11):7799-808. doi: 10.1074/jbc.M610159200. Epub 2007 Jan 17. J Biol Chem. 2007. PMID: 17229728 Free article.

4

Cell competition with normal epithelial cells promotes apical extrusion of transformed cells through metabolic changes.

Kon S, Ishibashi K, Katoh H, Kitamoto S, Shirai T, Tanaka S, Kajita M, Ishikawa S, Yamauchi H, Yako Y, Kamasaki T, Matsumoto T, Watanabe H, Egami R, Sasaki A, Nishikawa A, Kameda I, Maruyama T, Narumi R, Morita T, Sasaki Y, Enoki R, Honma S, Imamura H, Oshima M, Soga T, Miyazaki JI, Duchen MR, Nam JM, Onodera Y, Yoshioka S, Kikuta J, Ishii M, Imajo M, Nishida E, Fujioka Y, Ohba Y, Sato T, Fujita Y. Kon S, et al. Nat Cell Biol. 2017 May;19(5):530-541. doi: 10.1038/ncb3509. Epub 2017 Apr 17. Nat Cell Biol. 2017. PMID: 28414314 Free article.

5

MBNL1 associates with YB-1 in cytoplasmic stress granules.

Onishi H, Kino Y, Morita T, Futai E, Sasagawa N, Ishiura S. Onishi H, et al. J Neurosci Res. 2008 Jul;86(9):1994-2002. doi: 10.1002/jnr.21655. J Neurosci Res. 2008. PMID: 18335541

6

Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study.

Goto K, Annan DA, Morita T, Li W, Muroyama R, Matsubara Y, Ito S, Nakagawa R, Tanoue Y, Jinushi M, Kato N. Goto K, et al. Sci Rep. 2016 Dec 2;6:38407. doi: 10.1038/srep38407. Sci Rep. 2016. PMID: 27910927 Free PMC article.

7

The cell competition-based high-throughput screening identifies small compounds that promote the elimination of RasV12-transformed cells from epithelia.

Yamauchi H, Matsumaru T, Morita T, Ishikawa S, Maenaka K, Takigawa I, Semba K, Kon S, Fujita Y. Yamauchi H, et al. Sci Rep. 2015 Oct 20;5:15336. doi: 10.1038/srep15336. Sci Rep. 2015. PMID: 26480891 Free PMC article.

8

Autophagy-dependent regulation of tumor metastasis by myeloid cells.

Jinushi M, Morita T, Xu Z, Kinoshita I, Dosaka-Akita H, Yagita H, Kawakami Y. Jinushi M, et al. PLoS One. 2017 Jul 7;12(7):e0179357. doi: 10.1371/journal.pone.0179357. eCollection 2017. PLoS One. 2017. PMID: 28686632 Free PMC article.

9

The Coordinated Actions of TIM-3 on Cancer and Myeloid Cells in the Regulation of Tumorigenicity and Clinical Prognosis in Clear Cell Renal Cell Carcinomas.

Komohara Y, Morita T, Annan DA, Horlad H, Ohnishi K, Yamada S, Nakayama T, Kitada S, Suzu S, Kinoshita I, Dosaka-Akita H, Akashi K, Takeya M, Jinushi M. Komohara Y, et al. Cancer Immunol Res. 2015 Sep;3(9):999-1007. doi: 10.1158/2326-6066.CIR-14-0156. Epub 2015 Mar 17. Cancer Immunol Res. 2015. PMID: 25783986

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page